| miR-135b down-regulated genes driving key pathways in glioblastoma cell proliferation, survival and migration/infiltration, suggesting possible tumor suppressor function. | glioblastoma, |
| the present study demonstrated that miR135a serves as a tumor suppressor in AML by targeting HOXA10, and miR135a may be a promising prognostic biomarker for AML patients. | None |
| miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. | lymphoma, |
| miR-135b functions as an oncogene in colorectal cancer | colorectal, |
| Galpha12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation. | liver, |
| miR-135b may function as an oncogene by inhibiting GK5 in glioblastoma. | glioblastoma, |
| Authors identify miR-135b as a key downsteam effector of oncogenic pathways and a potential target for CRC treatment | None |